Open Access<p>Oncological Outcome of Combining Cytoreductive Prostatectomy and Metastasis-Directed Radiotherapy in Patients with Prostate Cancer and Bone Oligometastases: A Retrospective Cohort Study</p>
Author(s) -
Peng Xue,
Ziyu Wu,
Kunpen Wang,
Guojun Gao,
Min Zhuang,
Miao Yan
Publication year - 2020
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s270882
Subject(s) - medicine , prostate cancer , androgen deprivation therapy , prostatectomy , oncology , radiation therapy , cohort , metastasis , retrospective cohort study , bone metastasis , cancer , prostate specific antigen , urology , prostate , hormonal therapy
The current standard of care for metastatic prostate cancer (mPCa) is androgen deprivation therapy (ADT) with or without anti-androgen and chemotherapy. The aim of this study was to evaluate the efficacy and safety of a multimodal approach including local primary tumor therapy, metastasis-directed therapy (MDT), and hormonal therapy in patients with oligometastatic prostate cancer (PCa).